Advanced search
Publication Cover
Expert Opinion on Drug Safety Volume 23, 2024 - Issue 4
Submit an article Journal homepage
496
Views
0
CrossRef citations to date
0
Altmetric
Original Research

A comprehensive analysis of liver safety across zibotentan oncology trials: knowledge of the past offers new perspectives on the present

Anna Fettiplacea Global Patient Safety, AstraZeneca, Cambridge, UKCorrespondence[email protected]
View further author information
,
Sherri Matis-Mitchellb Safety Analytics, Oncology R&D AstraZeneca, Wilmington, DE, USAView further author information
,
Oleksandr Molodetskyic Global Patient Safety, Biopharmaceuticals, Chief Medical Office, R&D, AstraZeneca, Gothenburg, SwedenView further author information
,
Malin Söderberghc Global Patient Safety, Biopharmaceuticals, Chief Medical Office, R&D, AstraZeneca, Gothenburg, SwedenView further author information
,
Jan Oscarssond Late-Stage Clinical Development, Cardiovascular, Renal, and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, SwedenView further author information
,
Min Line Biometrics Late-Stage Development, Cardiovascular, Renal, and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, Maryland, USAView further author information
,
Srivathsa Ravikirane Biometrics Late-Stage Development, Cardiovascular, Renal, and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, Maryland, USAView further author information
,
Martin Billgerf Safety Sciences Cardiovascular, Renal, and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, SwedenView further author information
&
Philip Amberyd Late-Stage Clinical Development, Cardiovascular, Renal, and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, SwedenView further author information
 show all
Pages 477-486 | Received 20 Dec 2023, Accepted 05 Mar 2024, Published online: 24 Mar 2024

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

Order Reprints Request Permissions

For more information please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.